Venvalo Group is a venture value optimization firm. We
work with entrepreneurs and CEOs in creating value from
potential at technologies-based enterprises.
The Venvalo group creates value from potential for emerging and micro-cap companies using their proprietary Methodology VVOTM. In every assignment, our primary goal is to achieve a significant increase of the transaction valuation and/or major increase in the stock price and trading volume. Venture Value Optimization involves implementing strategic initiatives that concurrently address all aspects of the enterprise, whether structural, financial, or operational. Results have shown that when the Venvalo team employs VVOTM Methodology, there is a significant impact on the organization’s ability to realize maximal value.
INVESTMENTS
CLIENTS
PARTNER
FUNDS
INVESTMENT
BANKERS
TRANSACTIONS
Boris Reznik is the Chairman of Venvalo Group. During his career spanning four decades, Dr. Reznik founded and built technology companies into market leaders, managed high growth, profitable enterprises, successfully worked with Fortune 500 and emerging companies as clients and partners. He has been an investor in multiple technology-based companies and has participated in many public and private fundings and mergers and acquisitions of technology-based companies, ranging from millions to billions.
Growing out of several venture-based organizations founded in the early to mid-nineties, Venvalo Group was formed to create, enhance, and extract optimal value from emerging and mid-market companies. The founders bring a wealth of experience and expertise to the new discipline of Venture Value Optimization.
Everything started in 1983 when young, newly arrived to the U.S., Dr. Reznik participated in his first IPO experience with high flying Teknekron (www.teknekroncorp.com). Teknekron provided Dr. Reznik not only with the liquidity transaction experience as well as opportunities to hone the art and science of building high growth, profitable science-intensive enterprises.
Over the years following, Dr. Reznik developed and applied the Venture Value Optimization methodologies to significantly increasing clients’ valuations in multiple M&A and IPO transactions. He has also worked with a number of public companies in drastically increasing their valuations and trading volume.
While Venvalo works with private and public companies in multiple industries, biotech in general, as well as Immunotherapy and regenerative medicine have specifically become its primary focus. It is of tremendous benefit that Venvalo’s partners have hundreds of patents and peer-reviewed publications in those areas of biotech.
Teknekron provided Dr. Reznik with both an opportunity to hone the art and science of building high valuation technology enterprises, as well as an ability of extracting that value through a liquidity transaction.
Contact us for more information about VVOTM methodology.
